In this study, when the mean increases in CD4 cells count were compared the difference was not significant for both groups of PLWHs in contrary to what had been reported as starting ART, particularly early during TB treatment, could jeopardize adherence to treatment and hence worsening of the immune response [20]. This evidence concerns the gene CD4 and tuberculosis.